Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.96160378 |
2 | negative regulation of cell killing (GO:0031342) | 4.96160378 |
3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.87107978 |
4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83929472 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76257758 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75556182 |
7 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.56943638 |
8 | neutrophil activation involved in immune response (GO:0002283) | 4.47348326 |
9 | NIK/NF-kappaB signaling (GO:0038061) | 4.38305936 |
10 | response to interleukin-15 (GO:0070672) | 4.20000568 |
11 | cellular response to interleukin-15 (GO:0071350) | 4.17712490 |
12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08723742 |
13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08723742 |
14 | negative regulation of interleukin-12 production (GO:0032695) | 4.02530039 |
15 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98056714 |
16 | positive regulation of humoral immune response (GO:0002922) | 3.93262362 |
17 | regulation of activation of Janus kinase activity (GO:0010533) | 3.92671521 |
18 | regulation of hypersensitivity (GO:0002883) | 3.85266446 |
19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85252618 |
20 | type I interferon signaling pathway (GO:0060337) | 3.84568168 |
21 | cellular response to type I interferon (GO:0071357) | 3.84568168 |
22 | response to type I interferon (GO:0034340) | 3.82139052 |
23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.69400416 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.61882462 |
25 | tolerance induction (GO:0002507) | 3.61175015 |
26 | positive regulation of type 2 immune response (GO:0002830) | 3.59657393 |
27 | positive regulation of interleukin-12 production (GO:0032735) | 3.57647222 |
28 | positive regulation of interferon-alpha production (GO:0032727) | 3.54025837 |
29 | regulation of antigen processing and presentation (GO:0002577) | 3.52159945 |
30 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52138228 |
31 | natural killer cell mediated immunity (GO:0002228) | 3.52138228 |
32 | T-helper 1 type immune response (GO:0042088) | 3.52081193 |
33 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49982657 |
34 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49982657 |
35 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.49692380 |
36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48228718 |
37 | response to host immune response (GO:0052572) | 3.48217075 |
38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48217075 |
39 | regulation of RIG-I signaling pathway (GO:0039535) | 3.45889413 |
40 | regulation of natural killer cell differentiation (GO:0032823) | 3.43130901 |
41 | neutrophil activation (GO:0042119) | 3.42038041 |
42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41407860 |
43 | myeloid dendritic cell differentiation (GO:0043011) | 3.40463720 |
44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39302903 |
45 | response to host (GO:0075136) | 3.37397103 |
46 | response to host defenses (GO:0052200) | 3.37397103 |
47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37397103 |
48 | granulocyte activation (GO:0036230) | 3.36424694 |
49 | cellular response to zinc ion (GO:0071294) | 3.35093919 |
50 | regulation of interferon-alpha production (GO:0032647) | 3.34633414 |
51 | detection of other organism (GO:0098543) | 3.33020188 |
52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31072737 |
53 | detection of biotic stimulus (GO:0009595) | 3.30738539 |
54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30436182 |
55 | response to muramyl dipeptide (GO:0032495) | 3.29878407 |
56 | regulation of T cell tolerance induction (GO:0002664) | 3.28836308 |
57 | detection of external biotic stimulus (GO:0098581) | 3.27667434 |
58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26627226 |
59 | positive regulation of tolerance induction (GO:0002645) | 3.24771982 |
60 | regulation of immunoglobulin secretion (GO:0051023) | 3.22533558 |
61 | cellular response to interferon-beta (GO:0035458) | 3.21862204 |
62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20937855 |
63 | regulation of necroptotic process (GO:0060544) | 3.20649863 |
64 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.19956354 |
65 | immunoglobulin mediated immune response (GO:0016064) | 3.18967044 |
66 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16419071 |
67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15793800 |
68 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.14225049 |
69 | defense response to protozoan (GO:0042832) | 3.14018420 |
70 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13058262 |
71 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.12161027 |
72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.11610804 |
73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11177824 |
74 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.10099198 |
75 | detection of bacterium (GO:0016045) | 3.09583622 |
76 | myeloid dendritic cell activation (GO:0001773) | 3.08535730 |
77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.05517499 |
78 | * negative thymic T cell selection (GO:0045060) | 3.05409804 |
79 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04621870 |
80 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03754225 |
81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03357886 |
82 | B cell receptor signaling pathway (GO:0050853) | 3.03349378 |
83 | response to peptidoglycan (GO:0032494) | 3.02563440 |
84 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.99626123 |
85 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98639677 |
86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98527573 |
87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97448580 |
88 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.96724132 |
89 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94860849 |
90 | * negative T cell selection (GO:0043383) | 2.94538778 |
91 | negative regulation of lipid storage (GO:0010888) | 2.94211393 |
92 | regulation of interleukin-12 production (GO:0032655) | 2.88912860 |
93 | necroptotic process (GO:0070266) | 2.88361303 |
94 | cellular extravasation (GO:0045123) | 2.88256927 |
95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87035401 |
96 | programmed necrotic cell death (GO:0097300) | 2.86685989 |
97 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86390858 |
98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.85711056 |
99 | modulation by symbiont of host immune response (GO:0052553) | 2.85711056 |
100 | positive regulation by symbiont of host defense response (GO:0052509) | 2.85711056 |
101 | modulation by symbiont of host defense response (GO:0052031) | 2.85711056 |
102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.85711056 |
103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.85711056 |
104 | regulation of cell killing (GO:0031341) | 2.85643135 |
105 | cytidine deamination (GO:0009972) | 2.85197726 |
106 | cytidine metabolic process (GO:0046087) | 2.85197726 |
107 | cytidine catabolic process (GO:0006216) | 2.85197726 |
108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.83626614 |
109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83085343 |
110 | positive regulation of cell killing (GO:0031343) | 2.83014048 |
111 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82937463 |
112 | response to interferon-beta (GO:0035456) | 2.82139961 |
113 | leukocyte mediated cytotoxicity (GO:0001909) | 2.80815241 |
114 | membrane raft organization (GO:0031579) | 2.80173964 |
115 | activated T cell proliferation (GO:0050798) | 2.79745296 |
116 | regulation of tolerance induction (GO:0002643) | 2.79277682 |
117 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79205292 |
118 | negative regulation of necroptotic process (GO:0060546) | 2.78977590 |
119 | response to protozoan (GO:0001562) | 2.78863066 |
120 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.77623137 |
121 | response to interferon-alpha (GO:0035455) | 2.76827894 |
122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76458313 |
123 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.75915901 |
124 | necrotic cell death (GO:0070265) | 2.74177600 |
125 | T cell migration (GO:0072678) | 2.73082456 |
126 | dendritic cell differentiation (GO:0097028) | 2.72726858 |
127 | respiratory burst (GO:0045730) | 2.72401027 |
128 | cytokine secretion (GO:0050663) | 2.72231370 |
129 | T cell costimulation (GO:0031295) | 2.72178570 |
130 | negative regulation of viral genome replication (GO:0045071) | 2.71424422 |
131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.68747777 |
132 | natural killer cell differentiation (GO:0001779) | 2.66680751 |
133 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66411098 |
134 | natural killer cell activation (GO:0030101) | 2.66227699 |
135 | leukocyte aggregation (GO:0070486) | 2.65369620 |
136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65166178 |
137 | regulation of T-helper cell differentiation (GO:0045622) | 2.64594981 |
138 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64369459 |
139 | regulation of cholesterol storage (GO:0010885) | 2.63071382 |
140 | superoxide anion generation (GO:0042554) | 2.61792568 |
141 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61309285 |
142 | growth hormone receptor signaling pathway (GO:0060396) | 2.60133373 |
143 | dendritic cell chemotaxis (GO:0002407) | 2.59330753 |
144 | T-helper cell differentiation (GO:0042093) | 2.58073035 |
145 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.58073035 |
146 | positive regulation of interleukin-2 production (GO:0032743) | 2.57394551 |
147 | regulation of response to interferon-gamma (GO:0060330) | 2.55765890 |
148 | positive regulation of B cell mediated immunity (GO:0002714) | 2.54478989 |
149 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.54478989 |
150 | cellular response to interferon-alpha (GO:0035457) | 2.54003776 |
151 | positive regulation of interleukin-17 production (GO:0032740) | 2.53317836 |
152 | cellular response to exogenous dsRNA (GO:0071360) | 2.52038159 |
153 | detection of molecule of bacterial origin (GO:0032490) | 2.51853720 |
154 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.51461354 |
155 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.51100525 |
156 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.49249188 |
157 | cellular response to interferon-gamma (GO:0071346) | 2.48600980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.99946705 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.40519965 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.39692776 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.98941230 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53370251 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.77309980 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56248296 |
8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.51834263 |
9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.44616234 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.28872283 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83408993 |
12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75985221 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.68128478 |
14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.67916185 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67844889 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.63509416 |
17 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.56513846 |
18 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52763963 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40369438 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34423076 |
21 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31635973 |
22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23745695 |
23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21956543 |
24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16611251 |
25 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07564332 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93755991 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92806598 |
28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.89468804 |
29 | * TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77848406 |
30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73605917 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69086321 |
32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68854986 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68479276 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68195473 |
35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.67963635 |
36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66226735 |
37 | MYB_26560356_Chip-Seq_TH2_Human | 1.65432893 |
38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62569397 |
39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57867662 |
40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57116353 |
41 | * MAF_26560356_Chip-Seq_TH1_Human | 1.53586251 |
42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50801751 |
43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.37981449 |
44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36112049 |
45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35315859 |
46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34278400 |
47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32735911 |
48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30844524 |
49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30085212 |
50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29903060 |
51 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29313424 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27326037 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26923531 |
54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26770222 |
55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26231939 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25353461 |
57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23338870 |
58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22533980 |
59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22158662 |
60 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16950077 |
61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16757529 |
62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16304110 |
63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13674516 |
64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13674516 |
65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12450074 |
66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11664682 |
67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11608362 |
68 | MYC_22102868_ChIP-Seq_BL_Human | 1.10370579 |
69 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10272646 |
70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09347853 |
71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09077940 |
72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08158149 |
73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07082964 |
74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05980494 |
75 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04875400 |
76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04756686 |
77 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01349725 |
78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00065851 |
79 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97428766 |
80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96731955 |
81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95319573 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94718185 |
83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93362437 |
84 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93117310 |
85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92556750 |
86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90709990 |
87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90437267 |
88 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90067456 |
89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89998558 |
90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86875667 |
91 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86296440 |
92 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86296440 |
93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86125051 |
94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84333401 |
95 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84251492 |
96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83543884 |
97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82800190 |
98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82570570 |
99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81202333 |
100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80075719 |
101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.79868177 |
102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79383530 |
103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79054776 |
104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78959094 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78780196 |
106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78688477 |
107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78257260 |
108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77818446 |
109 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.76430949 |
110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76257556 |
111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76059706 |
112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75902507 |
113 | * MAF_26560356_Chip-Seq_TH2_Human | 0.75770995 |
114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75230415 |
115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74857696 |
116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74727709 |
117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74593876 |
118 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.74386824 |
119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74056723 |
120 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.73071306 |
121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72639145 |
122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72471261 |
123 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72062063 |
124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.71616763 |
125 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71141250 |
126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.71087354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.55245731 |
2 | MP0009785_altered_susceptibility_to | 3.55574371 |
3 | * MP0000685_abnormal_immune_system | 3.46474375 |
4 | MP0003436_decreased_susceptibility_to | 3.23017545 |
5 | MP0002138_abnormal_hepatobiliary_system | 3.20455233 |
6 | * MP0002148_abnormal_hypersensitivity_rea | 3.11123122 |
7 | MP0003724_increased_susceptibility_to | 3.05046684 |
8 | MP0002166_altered_tumor_susceptibility | 2.93179198 |
9 | * MP0001790_abnormal_immune_system | 2.87872108 |
10 | * MP0005387_immune_system_phenotype | 2.87872108 |
11 | MP0005671_abnormal_response_to | 2.81342685 |
12 | * MP0005000_abnormal_immune_tolerance | 2.70960944 |
13 | MP0004510_myositis | 2.65278947 |
14 | MP0002006_tumorigenesis | 2.62412693 |
15 | MP0002254_reproductive_system_inflammat | 2.60603231 |
16 | * MP0005025_abnormal_response_to | 2.52271876 |
17 | * MP0001800_abnormal_humoral_immune | 2.44159780 |
18 | * MP0002419_abnormal_innate_immunity | 2.35113735 |
19 | * MP0002452_abnormal_antigen_presenting | 2.24405419 |
20 | * MP0002723_abnormal_immune_serum | 2.23310951 |
21 | MP0009764_decreased_sensitivity_to | 2.15861014 |
22 | MP0001853_heart_inflammation | 2.11744244 |
23 | MP0002139_abnormal_hepatobiliary_system | 1.99332173 |
24 | * MP0001819_abnormal_immune_cell | 1.98678625 |
25 | * MP0006082_CNS_inflammation | 1.96838326 |
26 | * MP0002420_abnormal_adaptive_immunity | 1.96034198 |
27 | MP0005360_urolithiasis | 1.93840335 |
28 | MP0001533_abnormal_skeleton_physiology | 1.74330878 |
29 | MP0002009_preneoplasia | 1.70723348 |
30 | MP0009840_abnormal_foam_cell | 1.68107763 |
31 | MP0003191_abnormal_cellular_cholesterol | 1.67738528 |
32 | * MP0001845_abnormal_inflammatory_respons | 1.66351612 |
33 | MP0006054_spinal_hemorrhage | 1.59555583 |
34 | MP0003303_peritoneal_inflammation | 1.58576957 |
35 | * MP0008469_abnormal_protein_level | 1.57100554 |
36 | * MP0002405_respiratory_system_inflammati | 1.56680018 |
37 | * MP0004947_skin_inflammation | 1.53629121 |
38 | * MP0003763_abnormal_thymus_physiology | 1.51589628 |
39 | MP0003950_abnormal_plasma_membrane | 1.50143302 |
40 | * MP0000716_abnormal_immune_system | 1.49494285 |
41 | MP0010155_abnormal_intestine_physiology | 1.47666625 |
42 | * MP0005310_abnormal_salivary_gland | 1.46900653 |
43 | MP0000569_abnormal_digit_pigmentation | 1.43353185 |
44 | MP0005464_abnormal_platelet_physiology | 1.43287369 |
45 | MP0005365_abnormal_bile_salt | 1.42224714 |
46 | MP0005085_abnormal_gallbladder_physiolo | 1.41043873 |
47 | MP0003045_fibrosis | 1.37237942 |
48 | MP0003448_altered_tumor_morphology | 1.36812877 |
49 | MP0008260_abnormal_autophagy | 1.36747883 |
50 | * MP0002398_abnormal_bone_marrow | 1.35520667 |
51 | MP0003866_abnormal_defecation | 1.34776618 |
52 | MP0005451_abnormal_body_composition | 1.31844693 |
53 | MP0003252_abnormal_bile_duct | 1.30414876 |
54 | MP0000703_abnormal_thymus_morphology | 1.29238940 |
55 | MP0003186_abnormal_redox_activity | 1.26583913 |
56 | MP0002277_abnormal_respiratory_mucosa | 1.24036420 |
57 | MP0008438_abnormal_cutaneous_collagen | 1.23663955 |
58 | MP0004381_abnormal_hair_follicle | 1.23449582 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.16677153 |
60 | MP0002933_joint_inflammation | 1.16362489 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.16127128 |
62 | MP0002998_abnormal_bone_remodeling | 1.15560266 |
63 | MP0002396_abnormal_hematopoietic_system | 1.15256400 |
64 | MP0000858_altered_metastatic_potential | 1.14806765 |
65 | MP0003075_altered_response_to | 1.14355072 |
66 | MP0001879_abnormal_lymphatic_vessel | 1.14003725 |
67 | MP0001873_stomach_inflammation | 1.13238182 |
68 | MP0002429_abnormal_blood_cell | 1.13185929 |
69 | MP0005076_abnormal_cell_differentiation | 1.12836298 |
70 | MP0004782_abnormal_surfactant_physiolog | 1.12577946 |
71 | MP0001851_eye_inflammation | 1.12260876 |
72 | MP0003828_pulmonary_edema | 1.12062896 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.11036498 |
74 | * MP0001346_abnormal_lacrimal_gland | 1.10786785 |
75 | * MP0009763_increased_sensitivity_to | 1.06031081 |
76 | * MP0001348_abnormal_lacrimal_gland | 1.05270963 |
77 | * MP0000689_abnormal_spleen_morphology | 1.03616117 |
78 | * MP0000609_abnormal_liver_physiology | 1.01577409 |
79 | * MP0002722_abnormal_immune_system | 1.01241935 |
80 | MP0001545_abnormal_hematopoietic_system | 0.99914059 |
81 | MP0005397_hematopoietic_system_phenotyp | 0.99914059 |
82 | MP0000343_altered_response_to | 0.98856160 |
83 | MP0005058_abnormal_lysosome_morphology | 0.97953038 |
84 | MP0003091_abnormal_cell_migration | 0.97492686 |
85 | MP0002877_abnormal_melanocyte_morpholog | 0.96415496 |
86 | MP0003300_gastrointestinal_ulcer | 0.95529689 |
87 | MP0005164_abnormal_response_to | 0.94647650 |
88 | MP0010329_abnormal_lipoprotein_level | 0.92328776 |
89 | MP0003705_abnormal_hypodermis_morpholog | 0.90096397 |
90 | MP0001542_abnormal_bone_strength | 0.89511739 |
91 | * MP0002163_abnormal_gland_morphology | 0.89467233 |
92 | MP0001881_abnormal_mammary_gland | 0.88974156 |
93 | MP0003453_abnormal_keratinocyte_physiol | 0.88256044 |
94 | MP0002132_abnormal_respiratory_system | 0.88110949 |
95 | MP0005166_decreased_susceptibility_to | 0.88091579 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.87128617 |
97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86689279 |
98 | MP0005083_abnormal_biliary_tract | 0.86585045 |
99 | MP0009278_abnormal_bone_marrow | 0.86029009 |
100 | * MP0000249_abnormal_blood_vessel | 0.85741765 |
101 | MP0003172_abnormal_lysosome_physiology | 0.85487440 |
102 | MP0003806_abnormal_nucleotide_metabolis | 0.84419858 |
103 | MP0005390_skeleton_phenotype | 0.83562921 |
104 | MP0004808_abnormal_hematopoietic_stem | 0.82811387 |
105 | MP0005319_abnormal_enzyme/_coenzyme | 0.81711533 |
106 | MP0000604_amyloidosis | 0.81109193 |
107 | MP0010368_abnormal_lymphatic_system | 0.79650637 |
108 | MP0010352_gastrointestinal_tract_polyps | 0.79359263 |
109 | MP0005623_abnormal_meninges_morphology | 0.79348183 |
110 | MP0002295_abnormal_pulmonary_circulatio | 0.78679251 |
111 | MP0003183_abnormal_peptide_metabolism | 0.78127981 |
112 | MP0002168_other_aberrant_phenotype | 0.76664450 |
113 | MP0005084_abnormal_gallbladder_morpholo | 0.76640516 |
114 | MP0003566_abnormal_cell_adhesion | 0.76346012 |
115 | * MP0002136_abnormal_kidney_physiology | 0.74663788 |
116 | MP0003279_aneurysm | 0.73514643 |
117 | MP0002060_abnormal_skin_morphology | 0.73365095 |
118 | MP0000767_abnormal_smooth_muscle | 0.71209504 |
119 | MP0005275_abnormal_skin_tensile | 0.70448620 |
120 | MP0005023_abnormal_wound_healing | 0.69284796 |
121 | MP0003795_abnormal_bone_structure | 0.69121762 |
122 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.67924520 |
123 | MP0001958_emphysema | 0.65911486 |
124 | MP0001243_abnormal_dermal_layer | 0.65185791 |
125 | MP0004883_abnormal_blood_vessel | 0.63962257 |
126 | MP0009765_abnormal_xenobiotic_induced | 0.63815671 |
127 | * MP0005332_abnormal_amino_acid | 0.63750582 |
128 | MP0000371_diluted_coat_color | 0.63445811 |
129 | MP0008057_abnormal_DNA_replication | 0.62688118 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.96241212 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.29181687 |
3 | Recurrent abscess formation (HP:0002722) | 4.83812713 |
4 | Optic neuritis (HP:0100653) | 4.76736729 |
5 | Retrobulbar optic neuritis (HP:0100654) | 4.76736729 |
6 | Orchitis (HP:0100796) | 4.74238303 |
7 | Myositis (HP:0100614) | 4.71489930 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.68901819 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.68645053 |
10 | * Increased IgM level (HP:0003496) | 4.08023417 |
11 | Recurrent fungal infections (HP:0002841) | 3.86248876 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.58722378 |
13 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.55924161 |
14 | Stomatitis (HP:0010280) | 3.53570498 |
15 | Abnormality of macrophages (HP:0004311) | 3.53244956 |
16 | Tetraparesis (HP:0002273) | 3.50871793 |
17 | Recurrent skin infections (HP:0001581) | 3.49144983 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.48486902 |
19 | * Vasculitis (HP:0002633) | 3.43817215 |
20 | Keratoconjunctivitis (HP:0001096) | 3.25405711 |
21 | * Autoimmune thrombocytopenia (HP:0001973) | 3.24525846 |
22 | Keratoconjunctivitis sicca (HP:0001097) | 3.21944011 |
23 | Gingivitis (HP:0000230) | 3.20452870 |
24 | Myocardial infarction (HP:0001658) | 3.17755467 |
25 | Recurrent viral infections (HP:0004429) | 3.10383436 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05024271 |
27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05024271 |
28 | Arterial thrombosis (HP:0004420) | 2.96290868 |
29 | Chronic otitis media (HP:0000389) | 2.93087084 |
30 | Spondylolisthesis (HP:0003302) | 2.92677869 |
31 | Aortic aneurysm (HP:0004942) | 2.91279177 |
32 | Pulmonary infiltrates (HP:0002113) | 2.86802609 |
33 | IgA deficiency (HP:0002720) | 2.86401536 |
34 | Recurrent bronchitis (HP:0002837) | 2.81946317 |
35 | Aortic dissection (HP:0002647) | 2.81345076 |
36 | Gastrointestinal infarctions (HP:0005244) | 2.78440913 |
37 | * Abnormality of T cell physiology (HP:0011840) | 2.73127576 |
38 | IgG deficiency (HP:0004315) | 2.72585130 |
39 | * Autoimmune hemolytic anemia (HP:0001890) | 2.71445707 |
40 | Pustule (HP:0200039) | 2.70894479 |
41 | Interstitial pulmonary disease (HP:0006530) | 2.70887619 |
42 | Amyloidosis (HP:0011034) | 2.69422240 |
43 | Meningitis (HP:0001287) | 2.68760539 |
44 | Basal ganglia calcification (HP:0002135) | 2.65452301 |
45 | Deep venous thrombosis (HP:0002625) | 2.64870424 |
46 | Chest pain (HP:0100749) | 2.64597945 |
47 | T lymphocytopenia (HP:0005403) | 2.62977678 |
48 | * Abnormality of T cell number (HP:0011839) | 2.62977678 |
49 | Periodontitis (HP:0000704) | 2.61815964 |
50 | Esophageal varix (HP:0002040) | 2.60414973 |
51 | Gingival bleeding (HP:0000225) | 2.57852333 |
52 | Vertebral compression fractures (HP:0002953) | 2.57745177 |
53 | * Hypergammaglobulinemia (HP:0010702) | 2.57742766 |
54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.55079177 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.55079177 |
56 | Agammaglobulinemia (HP:0004432) | 2.55057980 |
57 | Obstructive lung disease (HP:0006536) | 2.53694370 |
58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53694370 |
59 | Vascular tortuosity (HP:0004948) | 2.53445065 |
60 | Joint hemorrhage (HP:0005261) | 2.53269175 |
61 | Fatigue (HP:0012378) | 2.52957507 |
62 | Dilatation of the ascending aorta (HP:0005111) | 2.52419275 |
63 | Abnormality of the nasal mucosa (HP:0000433) | 2.50775823 |
64 | Peritonitis (HP:0002586) | 2.50285863 |
65 | Hemoptysis (HP:0002105) | 2.50176687 |
66 | Spontaneous hematomas (HP:0007420) | 2.47783327 |
67 | Cellulitis (HP:0100658) | 2.47053513 |
68 | Complement deficiency (HP:0004431) | 2.45579892 |
69 | Prolonged partial thromboplastin time (HP:0003645) | 2.45022098 |
70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45000647 |
71 | Pulmonary embolism (HP:0002204) | 2.42653161 |
72 | Arterial tortuosity (HP:0005116) | 2.42259874 |
73 | Abnormality of proline metabolism (HP:0010907) | 2.41546631 |
74 | Hydroxyprolinuria (HP:0003080) | 2.41546631 |
75 | Thick nail (HP:0001805) | 2.39920975 |
76 | * Joint swelling (HP:0001386) | 2.37811822 |
77 | Xanthomatosis (HP:0000991) | 2.37568556 |
78 | Axonal loss (HP:0003447) | 2.36894545 |
79 | Vacuolated lymphocytes (HP:0001922) | 2.35040104 |
80 | Encephalitis (HP:0002383) | 2.32346932 |
81 | Nasal polyposis (HP:0100582) | 2.32224880 |
82 | Polycythemia (HP:0001901) | 2.30784833 |
83 | Recurrent pneumonia (HP:0006532) | 2.30755262 |
84 | Abnormality of the pleura (HP:0002103) | 2.30025720 |
85 | Keratitis (HP:0000491) | 2.29960665 |
86 | Gastrointestinal stroma tumor (HP:0100723) | 2.28274826 |
87 | Increased IgE level (HP:0003212) | 2.28197845 |
88 | Thrombophlebitis (HP:0004418) | 2.27378897 |
89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.27091802 |
90 | Purpura (HP:0000979) | 2.25856675 |
91 | Glomerulopathy (HP:0100820) | 2.23881593 |
92 | IgM deficiency (HP:0002850) | 2.19826514 |
93 | Chronic sinusitis (HP:0011109) | 2.18666869 |
94 | Lymphopenia (HP:0001888) | 2.18556353 |
95 | Gangrene (HP:0100758) | 2.15174527 |
96 | * Urticaria (HP:0001025) | 2.14989631 |
97 | Emphysema (HP:0002097) | 2.13715494 |
98 | Anorexia (HP:0002039) | 2.13016331 |
99 | * Leukocytosis (HP:0001974) | 2.11303661 |
100 | Mitral stenosis (HP:0001718) | 2.11253949 |
101 | Nephritis (HP:0000123) | 2.10750134 |
102 | Skin ulcer (HP:0200042) | 2.10410857 |
103 | Abnormality of the prostate (HP:0008775) | 2.10362678 |
104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10032419 |
105 | Combined immunodeficiency (HP:0005387) | 2.09613393 |
106 | Chronic diarrhea (HP:0002028) | 2.09144393 |
107 | Inflammation of the large intestine (HP:0002037) | 2.08206582 |
108 | Epistaxis (HP:0000421) | 2.07081280 |
109 | Panhypogammaglobulinemia (HP:0003139) | 2.06769617 |
110 | Osteomyelitis (HP:0002754) | 2.05658243 |
111 | Acute hepatic failure (HP:0006554) | 2.04421113 |
112 | Abnormality of complement system (HP:0005339) | 2.04076182 |
113 | Papilloma (HP:0012740) | 2.03652357 |
114 | Verrucae (HP:0200043) | 2.03652357 |
115 | Cheilitis (HP:0100825) | 2.03499376 |
116 | Skin rash (HP:0000988) | 2.02855582 |
117 | Premature loss of primary teeth (HP:0006323) | 2.01880070 |
118 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01644372 |
119 | Xerostomia (HP:0000217) | 2.01404645 |
120 | Slow saccadic eye movements (HP:0000514) | 2.01148181 |
121 | Intrahepatic cholestasis (HP:0001406) | 2.01073248 |
122 | Severe combined immunodeficiency (HP:0004430) | 2.00969824 |
123 | Hemorrhage of the eye (HP:0011885) | 2.00761369 |
124 | Abnormality of the pericardium (HP:0001697) | 2.00359636 |
125 | Hematochezia (HP:0002573) | 2.00153581 |
126 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98913956 |
127 | Mucosal telangiectasiae (HP:0100579) | 1.98879026 |
128 | Glomerulonephritis (HP:0000099) | 1.98849404 |
129 | * Eosinophilia (HP:0001880) | 1.98703607 |
130 | Restrictive lung disease (HP:0002091) | 1.98446427 |
131 | Bronchitis (HP:0012387) | 1.97521206 |
132 | * Abnormality of T cells (HP:0002843) | 1.96718912 |
133 | Abnormality of the peritoneum (HP:0002585) | 1.96714542 |
134 | * Arthralgia (HP:0002829) | 1.90889443 |
135 | Gastrointestinal inflammation (HP:0004386) | 1.88895535 |
136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88423438 |
137 | Recurrent sinusitis (HP:0011108) | 1.87516521 |
138 | Persistence of primary teeth (HP:0006335) | 1.87453722 |
139 | Viral hepatitis (HP:0006562) | 1.85650392 |
140 | Lymphoma (HP:0002665) | 1.85404532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.22530421 |
2 | TBK1 | 3.65516766 |
3 | TYK2 | 3.32805187 |
4 | IKBKE | 3.23805663 |
5 | JAK3 | 3.07629902 |
6 | MAP3K13 | 2.87968881 |
7 | IKBKB | 2.86985630 |
8 | FGFR4 | 2.58415784 |
9 | MAP4K1 | 2.36035098 |
10 | TXK | 2.30151525 |
11 | CHUK | 2.22933357 |
12 | PIM2 | 2.22682389 |
13 | IRAK4 | 2.17710022 |
14 | JAK1 | 2.08117548 |
15 | PRPF4B | 1.89364852 |
16 | MST4 | 1.78632290 |
17 | IRAK3 | 1.74435148 |
18 | ERN1 | 1.69410840 |
19 | BLK | 1.69158193 |
20 | RIPK4 | 1.67925334 |
21 | CSK | 1.67108202 |
22 | FES | 1.62343840 |
23 | EPHB1 | 1.54894090 |
24 | FGFR3 | 1.51900266 |
25 | SYK | 1.51462242 |
26 | ZAP70 | 1.48095751 |
27 | KIT | 1.43678548 |
28 | EIF2AK3 | 1.42379789 |
29 | BMPR2 | 1.41166098 |
30 | EPHA3 | 1.39306592 |
31 | NEK9 | 1.29648871 |
32 | KDR | 1.25112363 |
33 | PBK | 1.24131341 |
34 | TESK1 | 1.22273712 |
35 | STK24 | 1.21168480 |
36 | TEC | 1.16451565 |
37 | JAK2 | 1.15493389 |
38 | BTK | 1.11103245 |
39 | HCK | 1.05469102 |
40 | ACVR1B | 1.05449291 |
41 | PIM1 | 1.04220784 |
42 | TGFBR2 | 1.01727958 |
43 | LCK | 0.98928818 |
44 | PTK6 | 0.97602004 |
45 | ITK | 0.97183844 |
46 | RPS6KA4 | 0.96454994 |
47 | GRK7 | 0.95763690 |
48 | INSRR | 0.93495858 |
49 | MAP3K12 | 0.92707203 |
50 | EIF2AK2 | 0.91857171 |
51 | PIK3CG | 0.89882238 |
52 | PRKCQ | 0.89602319 |
53 | STK10 | 0.87303484 |
54 | TIE1 | 0.86511453 |
55 | TAOK2 | 0.85715366 |
56 | TNK2 | 0.84649426 |
57 | LYN | 0.84568413 |
58 | TAOK1 | 0.81329085 |
59 | SIK1 | 0.80531136 |
60 | CAMKK2 | 0.79509251 |
61 | CSF1R | 0.78998521 |
62 | MELK | 0.78531139 |
63 | BMPR1B | 0.76563428 |
64 | PRKD2 | 0.73398260 |
65 | ABL2 | 0.72257766 |
66 | RIPK1 | 0.71352501 |
67 | CLK1 | 0.70557396 |
68 | NLK | 0.70075640 |
69 | LRRK2 | 0.69050914 |
70 | BMX | 0.68950481 |
71 | YES1 | 0.66964070 |
72 | ARAF | 0.66940310 |
73 | TGFBR1 | 0.66386083 |
74 | DDR2 | 0.65797246 |
75 | SIK3 | 0.65461056 |
76 | CDK6 | 0.65198765 |
77 | CDC42BPA | 0.64245615 |
78 | SMG1 | 0.64235163 |
79 | STK4 | 0.63615348 |
80 | ABL1 | 0.61449558 |
81 | TRPM7 | 0.61399036 |
82 | PTK2B | 0.60031506 |
83 | PDGFRB | 0.58366524 |
84 | MATK | 0.57963518 |
85 | DYRK1B | 0.57779233 |
86 | MAP3K2 | 0.56759566 |
87 | ERBB3 | 0.56591352 |
88 | MST1R | 0.56301285 |
89 | PKN1 | 0.55645687 |
90 | FGR | 0.55065270 |
91 | TAOK3 | 0.54571347 |
92 | MAPK11 | 0.54499786 |
93 | RAF1 | 0.53311920 |
94 | PRKCH | 0.52677293 |
95 | AKT3 | 0.52292664 |
96 | KSR2 | 0.52279898 |
97 | * PRKCD | 0.51855947 |
98 | EGFR | 0.50870823 |
99 | MYLK | 0.48296138 |
100 | TTN | 0.48263530 |
101 | IGF1R | 0.47037131 |
102 | KSR1 | 0.46384085 |
103 | MOS | 0.45373932 |
104 | MAPK12 | 0.44123915 |
105 | IRAK2 | 0.42299390 |
106 | MAP3K3 | 0.42274366 |
107 | MAP2K3 | 0.41848732 |
108 | PDK1 | 0.41616753 |
109 | HIPK2 | 0.40424341 |
110 | MAPK7 | 0.40169814 |
111 | BCKDK | 0.40006686 |
112 | NUAK1 | 0.39433889 |
113 | * MAPKAPK2 | 0.39411806 |
114 | PAK3 | 0.39404705 |
115 | GRK6 | 0.37348483 |
116 | INSR | 0.37159097 |
117 | MAP2K6 | 0.37156922 |
118 | IRAK1 | 0.36534684 |
119 | MARK3 | 0.34902115 |
120 | MAP3K11 | 0.32340725 |
121 | MAP3K5 | 0.32223688 |
122 | WNK1 | 0.31970687 |
123 | GRK1 | 0.31515900 |
124 | STK38 | 0.30699350 |
125 | PRKAA2 | 0.30327273 |
126 | STK3 | 0.29925818 |
127 | DAPK3 | 0.29796551 |
128 | NME2 | 0.28829534 |
129 | MAPK4 | 0.28292572 |
130 | MAP3K7 | 0.27368265 |
131 | MAP3K1 | 0.26167378 |
132 | RPS6KA5 | 0.25578774 |
133 | CDK4 | 0.24710478 |
134 | SRC | 0.23697139 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.41770752 |
2 | * Allograft rejection_Homo sapiens_hsa05330 | 3.19554249 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98321238 |
4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83711313 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73582459 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68634336 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67903862 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55069348 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29784270 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26271905 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12763422 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07765866 |
13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00627457 |
14 | * Measles_Homo sapiens_hsa05162 | 1.93220394 |
15 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89405797 |
16 | Malaria_Homo sapiens_hsa05144 | 1.83598987 |
17 | Asthma_Homo sapiens_hsa05310 | 1.82925513 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.82399147 |
19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80544316 |
20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78542872 |
21 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.71060273 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68868000 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61232669 |
24 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58302581 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.53025801 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52549951 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51998719 |
28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45497163 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44789495 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43665345 |
31 | * Influenza A_Homo sapiens_hsa05164 | 1.43621822 |
32 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34329680 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.27085206 |
34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26009048 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24469489 |
36 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.23244300 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20792255 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.17112336 |
39 | * Apoptosis_Homo sapiens_hsa04210 | 1.16417921 |
40 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12177266 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.10796622 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09831419 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07966741 |
44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07874545 |
45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07719753 |
46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03949560 |
47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01033274 |
48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95914609 |
49 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95766809 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 0.91867739 |
51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90017477 |
52 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.89560541 |
53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86844554 |
54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86100168 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83970290 |
56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83063051 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.80212442 |
58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79956540 |
59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78693965 |
60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78165031 |
61 | * Hepatitis B_Homo sapiens_hsa05161 | 0.76991143 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75868073 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74616710 |
64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74037398 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.71171267 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.70070612 |
67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66598737 |
68 | * p53 signaling pathway_Homo sapiens_hsa04115 | 0.64492088 |
69 | Lysosome_Homo sapiens_hsa04142 | 0.63829914 |
70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63600520 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62831878 |
72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61795474 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61033757 |
74 | Prion diseases_Homo sapiens_hsa05020 | 0.56972265 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56479245 |
76 | Prostate cancer_Homo sapiens_hsa05215 | 0.56363192 |
77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56290201 |
78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54905711 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51355288 |
80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51343052 |
81 | Focal adhesion_Homo sapiens_hsa04510 | 0.51174787 |
82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49788770 |
83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49547954 |
84 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49521874 |
85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49397153 |
86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48665783 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47334630 |
88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45872811 |
89 | ABC transporters_Homo sapiens_hsa02010 | 0.45416681 |
90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45024447 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43908117 |
92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43519545 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.42789077 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40935275 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40815544 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40597128 |
97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38537475 |
98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38521796 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38320120 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37292643 |
101 | Bladder cancer_Homo sapiens_hsa05219 | 0.36992015 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36060234 |
103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35575977 |
104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34997062 |
105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34977765 |
106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34929509 |
107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33230454 |
108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32562456 |
109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32134451 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.31642948 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29845874 |
112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29436038 |
113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27857668 |
114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27124892 |
115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26867272 |
116 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26820451 |
117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26515710 |
118 | Platelet activation_Homo sapiens_hsa04611 | 0.24933217 |
119 | Proteasome_Homo sapiens_hsa03050 | 0.24811234 |
120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23448383 |
121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.23190804 |
122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22737133 |
123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22412029 |
124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22394794 |
125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22275146 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.21459233 |
127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21361304 |
128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21122552 |
129 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.20631484 |
130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19064546 |
131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19044160 |
132 | Glioma_Homo sapiens_hsa05214 | 0.18144134 |